|  | Treatment group (N = 27) | Comparator (N = 31) | ||
---|---|---|---|---|---|
 |  | N | Mean ± SD | N | Mean ± SD |
ALT (IU/L) | Baseline | 27 | 18.9 ± 14.4 | 31 | 20.4 ± 14.1 |
Week 52 | 26 | 18.3 ± 19.9 | 29 | 19.3 ± 16.9 | |
AST (IU/L) | Baseline | 27 | 30.4 ± 7.5 | 31 | 32.3 ± 7.2 |
Week 52 | 26 | 28.2 ± 10.5 | 29 | 30.3 ± 13.0 | |
ALP (IU/L) | Baseline | 27 | 244.6 ± 164.2 | 31 | 274.0 ± 178.0 |
Week 52 | 26 | 298.0 ± 197.3 | 29 | 291.1 ± 162.6 | |
Cholesterol (mg/dL) | Baseline | 27 | 173.9 ± 26.8 | 31 | 170.7 ± 31.7 |
Week 52 | 26 | 166.9 ± 21.2 | 29 | 160.6 ± 22.5 | |
Triglyceride (mg/dL) | Baseline | 27 | 89.5 ± 61.6 | 31 | 119.9 ± 70.3 |
Week 52 | 26 | 99.5 ± 48.8 | 29 | 116.3 ± 89.0 | |
Hemoglobin A1c (%) | Baseline | 27 | 5.01 ± 0.44 | 31 | 5.17 ± 0.35 |
Week 52 | 26 | 5.17 ± 0.45 | 29 | 5.32 ± 0.27 | |
TSH (uIU/mL) | Baseline | 27 | 3.06 ± 1.51 | 31 | 3.13 ± 1.65 |
Week 52 | 26 | 2.81 ± 1.62 | 29 | 3.14 ± 2.16 | |
Free T4 (ng/ dL) | Baseline | 27 | 1.39 ± 0.27 | 31 | 1.37 ± 0.20 |
Week 52 | 26 | 1.36 ± 0.24 | 29 | 1.35 ± 0.18 |